Effects of Triacylglycerol Structure on Gut Hormones and Haemostatic Markers

The Acute Effects of Triacylglycerol Structure of Dietary Fats on Gut Hormones and Haemostatic Markers in Subjects With Type 2 Diabetes Mellitus

Type 2 diabetes mellitus (T2DM) is a chronic disorder determined by lifestyle and genes. It is associated with chronic hyperglycaemia along with other metabolic abnormalities. It is also one of the risk factors for cardiovascular disease (CVD). This disease is due to insulin resistance and/or deficiency as well as increased hepatic glucose output. According to the Third National Health and Morbidity Survey (3rd NHMS), the prevalence of T2DM for adults aged 30 years and above is 14.9%, increased by almost 80% from 1996 to 2006. Dietary composition may affect insulin sensitivity, postprandial triacylglycerol concentration and the risk of T2DM. The role of dietary fats in T2DM is of particular interest and has been clinically studied for many decades. The type of fat we ingest every day consists of different types of fatty acids and different degree of saturation, which in turn influence glucose metabolism by altering cell membrane function, enzyme activity, insulin signalling and gene expression. Previous studies demonstrated that interesterification of dietary fat alter postprandial lipaemia. Saturated fat such as palm olein has been reported to display lower postprandial lipaemia after interesterification. Changing the structure of triacylglycerol (TAG) alters the physical properties of dietary fat which affects digestibility, metabolism and atherogenicity. A recent study conducted by Sanders and co-workers demonstrated reduced levels of plasma glucose-dependent insulinotropic polypeptide (GIP) following both the lard and interesterified palm olein (IPO) compared with the palm olein (PO) and high oleic sunflower oil (HOS) diets in healthy subjects. The GIP and glucagon-like peptide-1 (GLP-1) are major players in the modulation of postprandial insulin secretion by the pancreas. Although GIP secretion in response to meals is normal in patients with Type 2 diabetes mellitus (T2DM), GIP induced secretion of insulin is defective in diabetes. This is observed to be predominantly a defective stimulation of the late phase of insulin response (20-120 minutes). The effect of IPO on GIP may be exaggerated in T2DM patients with impaired insulin sensitivity. Hence, IPO may change the concentrations of gut hormones, postprandial lipaemia, insulinaemic response and CVD related haemostatic markers.

Subjects aged between 30 and 60 years old (male and female) with Type 2 diabetes mellitus (T2DM) will be recruited for this study. A randomized, crossover, double-blind study design will be carried out to investigate the acute effects of high fat meals prepared using palm olein (PO), chemically interesterified palm olein (IPO) and high oleic sunflower oil (HOS) (control) on study subjects with T2DM. Study subjects will have to undergo three postprandial challenges, separated by at least one week interval. Fasting blood sample and duplicate baseline blood samples will be taken in the morning of postprandial day. After that, subjects will be asked to consume a test meal consisting a high fat muffin baked using the aforementioned oils and a milkshake within 10 minutes. After meal, venous blood samples will be taken at time-points 15, 30, 60, 90, 120 min, 3 h, 4 h, 5 h, 6 h and post-heparin plasma 5 min and 15 min for analysis. Pulse wave analysis will be conducted to evaluate central blood pressure and arterial stiffness. Meal appreciation will be assessed by utilising visual analogue scale (VAS) before eating, after eating and at each time-point.

Inclusion Criteria:

1. Mild T2DM individuals not planned for medical intervention

   • 7.0 mmol/L ≤ fasting glucose ≤ 11.1 mmol/L
   • 6.5% ≤ HbA1c ≤ 9.0%
   • Not using antihypertensive, lipid lowering, insulin/glucose modulating medication

2. Mild T2DM individuals currently on medical intervention

   • Fasting glucose ≤ 11.1 mmol/L
   • HbA1c ≤ 9.0%
   • Using antihypertensive, lipid lowering or glucose modulating medication

3. Malaysian male or female with T2DM aged between 30 to 60 years old

4. Not using insulin

5. Not having any complications of diabetes

6. No medical history of myocardial infarction, angina, thrombosis, stroke or cancer

7. Haemoglobin levels for females ≥ 11.5 gm/dl and males ≥ 12.5 gm/dl

8. Serum ferritin > 15 µg/l at commencement of study

Exclusion Criteria:

1. Medical history of myocardial infarction, angina, thrombosis, stroke or cancer
2. Underweight (BMI < 18.5 kg/m²)
3. Using insulin
4. Total cholesterol > 7.0 mmol/L
5. Abnormal liver function, renal function and haematology
6. Hypersensitive towards heparin
7. Gastric or lactose intolerance
8. Smoker
9. Pregnancy and lactating
10. Taking alcohol
11. Taking alcohol
12. Haemoglobin levels for females ≤ 11.5 gm/dl and males ≤ 12.5 gm/dl
13. Serum ferritin < 15 µg/l at commencement of study